pharma · Becker Muscular Dystrophy · Muscular Dystrophies · EWTX
Edgewise Therapeutics
Edgewise Therapeutics clinical programs — 10 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1715 38th St., Boulder, CO 80301, US
- Founded
- 2017
- Employees
- 154
- Programs
- 15
- Drugs
- 3
- Patents
- 7
Edgewise Therapeutics projects
10 ClinicalTrials.gov programs sponsored by Edgewise Therapeutics.
Edgewise Therapeutics has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
EDG-15400
Edgewise Therapeutics
Healthy Adults
1 trial -
EDG-5506
Edgewise Therapeutics
Healthy Volunteer
1 trial -
EDG-5506
Edgewise Therapeutics
Muscular Dystrophies
1 trial -
EDG-5506 Tablet
Edgewise Therapeutics
Healthy Volunteer
1 trial -
EDG-7500
Edgewise Therapeutics
Hepatic Impairment (HI)
1 trial -
EDG-7500
Edgewise Therapeutics
Healthy Adult Participants
1 trial -
EDG-7500
Edgewise Therapeutics
Healthy Subjects
1 trial -
EDG-7500
Edgewise Therapeutics
Renal Impairments
1 trial -
[14C]-EDG-7500
Edgewise Therapeutics
Healthy Volunteer
1 trial -
sevasemten
Edgewise Therapeutics
Healthy Subjects
1 trial
Frequently asked questions
How many clinical projects does Edgewise Therapeutics have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.